High serum levels of ustekinumab are associated with better clinical outcomes during maintenance treatment for inflammatory bowel disease.
Jaime González-AntuñaValdés Delgado TeresaBelén Maldonado-PérezMaría Belvis-JiménezLuisa Castro-LariaVicente Merino-BohórquezMiguel Ángel Calleja-HernándezPaula Castro-MartínezCloe CharpentierFederico Argüelles-AriasPublished in: Therapeutic advances in gastroenterology (2024)
High serum levels of UST were associated with clinical remission during treatment for IBD under intensification treatment, with a cutoff point of 6.3 μg/mL.
Keyphrases